Thermo Fisher joins King Abdullah International Medical Research Center in genomics project
The Saudi National Biotechnology Strategy aims to create 11,000 jobs by 2030 and contribute $34.6 billion to non-oil GDP by 2040. Agreements signed at the Riyadh Global Medical Biotechnology Summit in September include partnerships with Thermo Fisher Scientific and Olink.
- Field
- business and funding
- What they did
- Saudi Arabia launched a National Biotechnology Strategy aiming for a $34.6 billion contribution to non-oil GDP by 2040 and 11,000 jobs by 2030.
- Why it matters
- This provides clear direction for investors and drug developers regarding access to clinical trials, local manufacturing, and capital for local partners and staff.
#saudi arabia#biotech#strategy#funding#clinical trial



